Chronic Heart Failure Global Clinical Trials Review, H1, 2019

GlobalData's clinical trial report, “Chronic Heart Failure Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Novartis AG

Bayer AG

Les Laboratoires Servier SAS

Orion Corp

Zensun (Shanghai) Sci & Tech Co Ltd

Vifor Pharma Ltd

Cytokinetics Inc

GlaxoSmithKline Plc

C ...

Novartis AG

Bayer AG

Les Laboratoires Servier SAS

Orion Corp

Zensun (Shanghai) Sci & Tech Co Ltd

Vifor Pharma Ltd

Cytokinetics Inc

GlaxoSmithKline Plc

C. H. Boehringer Sohn AG & Co KG

Eli Lilly and Co

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region ...

Table of Contents 2

List of Tables 4

List of Figures 5

Report Guidance 6

GlobalData Clinical Trials Report Coverage 7

Clinical Trials by Region 8

Clinical Trials and Average Enrollment by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12

Top Five Countries Contributing to Clinical Trials in Europe 13

Top Countries Contributing to Clinical Trials in North America 14

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15

Top Five Countries Contributing to Clinical Trials in Central and South America 16

Clinical Trials by G7 Countries: Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials 17

Clinical Trials by Phase in G7 Countries 19

Clinical Trials in G7 Countries by Trial Status 20

Clinical Trials by E7 Countries: Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials 22

Clinical Trials by Phase in E7 Countries 24

Clinical Trials in E7 Countries by Trial Status 25

Clinical Trials by Phase 27

In Progress Trials by Phase 28

Clinical Trials by Trial Status 29

Clinical Trials by End Point Status 31

Subjects Recruited Over a Period of Time 32

Clinical Trials by Sponsor Type 33

Prominent Sponsors 34

Top Companies Participating in Chronic Heart Failure Therapeutics Clinical Trials 36

Prominent Drugs 38

Latest Clinical Trials News on Chronic Heart Failure 39

Mar 22, 2019: Amgen, Cytokinetics and Servier heart failure drug trial to continue 39

Mar 18, 2019: Cytokinetics announces presentation of additional results from COSMIC-HF at ACC.19 39

Mar 11, 2019: AstraZeneca to present data on Farxiga at American College of Cardiology's 68th Annual Scientific Session 40

Mar 11, 2019: Cytokinetics announces additional results from COSMIC-HF to be presented at ACC.19 40

Mar 06, 2019: New data from Amgen to be presented at ACC.19 continues to build evidence for Repatha (evolocumab) across multiple patient populations 40

Mar 06, 2019: Dose response of beta-blockers in adrenergic receptor polymorphism genotypes paper published in Circulation: Genomic and Precision Medicine 42

Feb 22, 2019: Amgen and Cytokinetics begins omecamtiv mecarbil’s trial 42

Feb 19, 2019: Final patient dosed in Mesoblast phase 3 trial of Revascor cell therapy for advanced heart failure 43

Clinical Trial Profile Snapshots 44

Appendix 388

Abbreviations 388

Definitions 388

Research Methodology 389

Secondary Research 389

About GlobalData 390

Contact Us 390

Source 391

List of Tables

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Region, 2019* 8

Chronic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019 ...

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Region, 2019* 8

Chronic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Chronic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12

Chronic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13

Chronic Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2019* 14

Chronic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15

Chronic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16

Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 17

Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 22

Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24

Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2019* 27

Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 28

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Chronic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31

Chronic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32

Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 33

Chronic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Chronic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Chronic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38

List of Figures

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Chronic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019 ...

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2019* 8

Chronic Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9

Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11

Chronic Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12

Chronic Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13

Chronic Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14

Chronic Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15

Chronic Heart Failure Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16

Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2019* 17

Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 19

Chronic Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 20

Proportion of Chronic Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2019* 22

Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 24

Chronic Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 25

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2019* 27

Chronic Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 28

Chronic Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2019* 29

Chronic Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2019* 31

Chronic Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 32

Chronic Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 33

Chronic Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 34

Chronic Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 36

Chronic Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 38

GlobalData Methodology 389

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports